Pancreatic Cancer Research

ResearcherUniversity of Nebraska–LincolnNo recent work listed

Saber Tadros

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2887-6122; OpenAlex author ID A5087929619. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2017: 2 papers

Papers 2

  1. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jproteome.7b00246↗
  2. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-3062↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nina V. Chaika · 2 shared papers, 2017 · strength 0.13
  2. Jaime Abrego · 2 shared papers, 2017 · strength 0.13
  3. Venugopal Gunda · 2 shared papers, 2017 · strength 0.13
  4. Pankaj Kumar Singh · 2 shared papers, 2017 · strength 0.13
  5. Surendra Kumar Shukla · 2 shared papers, 2017 · strength 0.13
  6. Vinee Purohit · 1 shared paper, 2017 · strength 0.07
  7. Robert Powers · 1 shared paper, 2017 · strength 0.07
  8. Teklab Gebregiworgis · 1 shared paper, 2017 · strength 0.07
  9. Scott E. Mulder · 1 shared paper, 2017 · strength 0.07
  10. Jean L. Grem · 1 shared paper, 2017 · strength 0.06
  11. Enza Vernucci · 1 shared paper, 2017 · strength 0.06
  12. Ryan J. King · 1 shared paper, 2017 · strength 0.06
  13. Lyudmyla Derby Berim · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.